Suppr超能文献

黏附性格列吡嗪微球的制剂与评价

Formulation and evaluation of mucoadhesive glipizide microspheres.

作者信息

Patel Jayvadan K, Patel Rakesh P, Amin Avani F, Patel Madhabhai M

机构信息

Shree S.K. Patel College of Pharmaceutical Education and Research, Ganpat Vidyanagar, Mehsana-Gozaria Highway, Kherva-382711, India.

出版信息

AAPS PharmSciTech. 2005 Sep 20;6(1):E49-55. doi: 10.1208/pt060110.

Abstract

The purpose of this research was to formulate and systematically evaluate in vitro and in vivo performances of mucoadhesive microspheres of glipizide. Glipizide microspheres containing chitosan were prepared by simple emulsification phase separation technique using glutaraldehyde as a cross-linking agent. Results of preliminary trials indicate that volume of cross-linking agent, time for cross-linking, polymer-to-drug ratio, and speed of rotation affected characteristics of microspheres. Microspheres were discrete, spherical, and free flowing. The microspheres exhibited good mucoadhesive property in the in vitro wash-off test and also showed a high percentage drug entrapment efficiency. A 3(2) full factorial design was employed to study the effect of independent variables, polymer-to-drug ratio (X(1) ), and stirring speed (X(2) ) on dependent variables percentage mucoadhesion, t(80), drug entrapment efficiency, and swelling index. The best batch exhibited a high drug entrapment efficiency of 75% and a swelling index of 1.42; percentage mucoadhesion after 1 hour was 78%. The drug release was also sustained for more than 12 hours. The polymer-to-drug ratio had a more significant effect on the dependent variables. In vivo testing of the mucoadhesive microspheres to albino Wistar rats demonstrated significant hypoglycemic effect of glipizide.

摘要

本研究的目的是制备格列吡嗪黏膜黏附微球并对其体外和体内性能进行系统评价。以壳聚糖为载体,戊二醛为交联剂,采用简单乳化相分离技术制备格列吡嗪微球。初步试验结果表明,交联剂用量、交联时间、聚合物与药物比例以及搅拌速度对微球特性有影响。微球呈离散球形,流动性良好。在体外冲洗试验中,微球表现出良好的黏膜黏附性,且药物包封率较高。采用3(2)全因子设计研究自变量聚合物与药物比例(X(1))和搅拌速度(X(2))对因变量黏膜黏附百分比、t(80)、药物包封率和溶胀指数的影响。最佳批次的药物包封率高达75%,溶胀指数为1.42;1小时后的黏膜黏附百分比为78%。药物释放也持续了12小时以上。聚合物与药物比例对因变量的影响更为显著。对白化Wistar大鼠进行的格列吡嗪黏膜黏附微球体内试验表明,其具有显著的降血糖作用。

相似文献

1
Formulation and evaluation of mucoadhesive glipizide microspheres.
AAPS PharmSciTech. 2005 Sep 20;6(1):E49-55. doi: 10.1208/pt060110.
4
Lacidipine encapsulated gastroretentive microspheres prepared by chemical denaturation for pylorospasm.
J Microencapsul. 2009 Aug;26(5):385-93. doi: 10.1080/02652040802376429.
6
Study of the Mucoadhesive Potential of Carbopol Polymer in the Preparation of Microbeads Containing the Antidiabetic Drug Glipizide.
AAPS PharmSciTech. 2016 Jun;17(3):743-56. doi: 10.1208/s12249-015-0396-8. Epub 2015 Sep 4.
10
Design, in vitro and in vivo evaluation of glipizide Eudragit microparticles.
J Microencapsul. 2010;27(4):281-91. doi: 10.3109/02652040903131319.

引用本文的文献

1
Development of a mucoadhesive drug delivery system and its interaction with gastric cells.
Beilstein J Nanotechnol. 2025 Mar 13;16:371-384. doi: 10.3762/bjnano.16.28. eCollection 2025.
2
Amphiphilic, lauric acid-coupled pluronic-based nano-micellar system for efficient glipizide delivery.
Saudi Pharm J. 2024 May;32(5):102046. doi: 10.1016/j.jsps.2024.102046. Epub 2024 Mar 21.
5
Palmitic Acid-Pluronic F127-Palmitic Acid Pentablock Copolymer as a Novel Nanocarrier for Oral Delivery of Glipizide.
Turk J Pharm Sci. 2019 Sep;16(3):265-272. doi: 10.4274/tjps.galenos.2018.20082. Epub 2019 Jul 10.
6
Preparation, Optimization and In vitro Evaluation of Glipizide Nanoparticles Integrated with Eudragit RS-100.
Pharm Nanotechnol. 2019;7(1):72-85. doi: 10.2174/2211738507666190319124513.
7
Formulation and evaluation of controlled-release of telmisartan microspheres: In vitro/in vivo study.
J Food Drug Anal. 2014 Dec;22(4):542-548. doi: 10.1016/j.jfda.2014.05.001. Epub 2014 Aug 8.
9
Development of floating chitosan-xanthan beads for oral controlled release of glipizide.
Int J Pharm Investig. 2015 Apr-Jun;5(2):73-80. doi: 10.4103/2230-973X.153381.

本文引用的文献

1
Two-stage optimization process for formulation of chitosan microspheres.
AAPS PharmSciTech. 2004 Feb 6;5(1):E5. doi: 10.1208/pt050105.
5
Bioadhesive microspheres as a controlled drug delivery system.
Int J Pharm. 2003 Apr 14;255(1-2):13-32. doi: 10.1016/s0378-5173(03)00087-5.
8
Glipizide. A review of the pharmacoeconomic implications of the extended-release formulation in type 2 diabetes mellitus.
Pharmacoeconomics. 2000 Sep;18(3):289-306. doi: 10.2165/00019053-200018030-00008.
9
Bioadhesive-based dosage forms: the next generation.
J Pharm Sci. 2000 Jul;89(7):850-66. doi: 10.1002/1520-6017(200007)89:7<850::AID-JPS2>3.0.CO;2-G.
10
Delivery of glipizide from asymmetric membrane capsules using encapsulated excipients.
J Control Release. 1999 Aug 5;60(2-3):333-41. doi: 10.1016/s0168-3659(99)00086-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验